Stock MVP MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Medical Developments International Limited

Equities

MVP

AU000000MVP2

Delayed Australian S.E.
Other stock markets
 08:33:54 2024-05-07 pm EDT 		5-day change 1st Jan Change
0.445 AUD +1.14% Intraday chart for Medical Developments International Limited -3.26% -41.45%
Apr. 29 Transcript : Medical Developments International Limited, Q3 2024 Earnings Call, Apr 29, 2024
Feb. 29 Transcript : Medical Developments International Limited, H1 2024 Earnings Call, Feb 29, 2024

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Medical Developments International : US FDA Investor Presentation
PU
Medical Developments International : MVP FY22 Half Year Investor Presentation
PU
Medical Developments International : FY22 Half Year Report and Accounts
PU
Medical Developments International : Penthrox is approved in Saudi Arabia
PU
Medical Developments International : Share Purchase Plan
PU
Medical Developments International : Capital Raising – Placement and Share Purchase Plan
PU
Medical Developments International : USA Update
PU
Medical Developments International : Penthrox approved in Italy, The Czech Republic and Spain
PU
Medical Developments International : Penthrox approved in Portugal and Switzerland
PU
Medical Developments International : MVP signs exclusive Distribution Deal for Iran
PU
Medical Developments International : Penthrox is approved in Canada
PU
Medical Developments International : Stage II success for new manufacturing technology – Lidocaine
PU
Medical Developments International : MVP signs major deal with Walgreens in the USA
PU
Medical Developments International : Penthrox approved in Mexico
PU
Medical Developments International : Penthrox is recommended for use in all UK ambulances
PU
Medical Developments International : MVP signs Respiratory Device supply deal with Sam’s Club
PU
Medical Developments International : Penthrox Regulatory Dossier accepted for review in Canada
PU
Medical Developments International : Presentation at Jefferies 2017 Global Healthcare Conference – June 9, New York
PU
Medical Developments International : MVP signs significant Manufacturing Development Project with CSIRO
PU
Medical Developments International : Penthrox replaces Nitrous Oxide in New Zealand Ambulance
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MVP Stock
  4. News Medical Developments International Limited
  5. Press Releases
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW